Abstract:Non-alcoholic fatty liver disease (NAFLD) is affecting up to one-third of the general population in western countries. While the major cause of NAFLD is related to an unhealthy lifestyle, recent evidence has shown a role of chemical exposure in the induction and progression of NAFLD. Perfluorooctanoate (PFOA) is a ubiquitous environmental contaminant that exerts its hepatotoxicity mainly through the activation of peroxisome proliferator-activated receptor α (PPARα). We examined how PFOA might affect the progression of NAFLD and whether a preexisting fatty liver intensified or alleviated the effects of PFOA in the livers. As such, male C57BL/6 mice were fed with a low-fat control diet (CD) or a high fat diet (HFD) for 16 weeks to model normal or steatotic livers, respectively. Mice were then administered with PFOA (1mg/kg/d) by oral gavage for an additional 2, 8, and 16 weeks. Dietary treatment was continued throughout the whole study. We found HFD induced hepatic steatosis, lobular inflammation, and progressive fibrosis in mice. As expected, PFOA activated PPARα, constitutive androstane receptor (CAR) and pregnane X receptor (PXR), regardless of the diet. Gene expression analysis showed the interactions between HFD and PFOA on hepatic nuclear receptors were time-dependent. Hepatocytes growth as measured by DNA synthesis and cell growth genes induced by PFOA were exacerbated in the HFD group after 2 weeks, along with the enhanced activation of PPARα. In contrast, PFOA decreased the severity of hepatic steatosis. In HFD-fed mice, the hepatic triglyceride levels were reduced to 75%, 47%, and 40%, after 2, 8, and 16 weeks of PFOA treatment, respectively, compared to vehicle controls. Transcriptomic analysis showed the preexisting NAFLD enhanced PFOA related lipid oxidation pathways in mice. HFD induced hepatic fibrosis as measured by collagen staining and fibrosis gene markers were also attenuated by PFOA. Taken together, this study demonstrated that the preexisting NAFLD might impact on many biological effects induced by PFOA and thus need to be carefully considered as a factor in risk assessment.

High Perfluorooctanoic Acid Exposure Induces Autophagy Blockage and Disturbs Intracellular Vesicle Fusion in the Liver

Perfluorooctanoic Acid Exposure Induces Endoplasmic Reticulum Stress in the Liver and Its Effects Are Ameliorated by 4-Phenylbutyrate

Perfluorooctanoic acid induces hepatocellular endoplasmic reticulum stress and mitochondrial-mediated apoptosis in vitro via endoplasmic reticulum-mitochondria communication

Hepatotoxicity of perfluorooctanoic acid in human hepatocytes using metabonomics: Hepatotoxicity of perfluorooctanoic acid in human hepatocytes using metabonomics

An integrated metabonomics and transcriptomics approach to understanding metabolic pathway disturbance induced by perfluorooctanoic acid.

Perfluorooctane Sulfonate Induced Toxicity in Embryonic Stem Cell-Derived Cardiomyocytes Via Inhibiting Autophagy-Lysosome Pathway.

Perfluorooctane Sulfonate Induces Autophagy-Dependent Apoptosis Through Spinster 1-Mediated Lysosomal-Mitochondrial Axis and Impaired Mitophagy

High Fat Diet Feeding Exaggerates Perfluorooctanoic Acid-Induced Liver Injury in Mice via Modulating Multiple Metabolic Pathways

Effect of Acute Exposure to PFOA on Mouse Liver Cells in Vivo and in Vitro

Perfluorooctanoic acid inhibits cell proliferation through mitochondrial damage

Molecular Mechanisms of Perfluorooctanoate-Induced Hepatocyte Apoptosis in Mice Using Proteomic Techniques.

Perfluorooctanoic acid-induced liver injury is potentially associated with gut microbiota dysbiosis

The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.

Probing the Cell Apoptosis Pathway Induced by Perfluorooctanoic Acid and Perfluorooctane Sulfonate at the Subcellular and Molecular Levels.

Effects of Perfluorooctanoic Acid on Metabolic Profiles in Brain and Liver of Mouse Revealed by a High-throughput Targeted Metabolomics Approach

Perfluorooctanoic acid (PFOA) affects distinct molecular signalling pathways in human primary hepatocytes

Perfluorooctanoic acid induces apoptosis through the p53-dependent mitochondrial pathway in human hepatic cells: a proteomic study.

Perfluorooctane Sulfonate Induces Mitochondrial Calcium Overload and Early Hepatic Insulin Resistance Via Autophagy/detyrosinated Alpha-Tubulin-regulated IP3R2-VDAC1-MICU1 Interaction

Environment Relevant Exposure of Perfluorooctanoic Acid Accelerates the Growth of Hepatocellular Carcinoma Cells Through Mammalian Target of Rapamycin (mtor) Signal Pathway.

Effects of perfluorooctanoate and perfluorooctane sulfonate exposure on hepatoma Hep G2 cells

Perfluorooctanoic acid induces Leydig cell injury via inhibition of autophagosomes formation and activation of endoplasmic reticulum stress